Lin, M.-W.; Lin, C.-H.; Chiang, H.-H.; Quintela, I.A.; Wu, V.C.H.; Lin, C.-S.
Using Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers. BioTech 2025, 14, 20.
https://doi.org/10.3390/biotech14010020
AMA Style
Lin M-W, Lin C-H, Chiang H-H, Quintela IA, Wu VCH, Lin C-S.
Using Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers. BioTech. 2025; 14(1):20.
https://doi.org/10.3390/biotech14010020
Chicago/Turabian Style
Lin, Meng-Wei, Cheng-Han Lin, Hua-Hsin Chiang, Irwin A. Quintela, Vivian C. H. Wu, and Chih-Sheng Lin.
2025. "Using Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers" BioTech 14, no. 1: 20.
https://doi.org/10.3390/biotech14010020
APA Style
Lin, M.-W., Lin, C.-H., Chiang, H.-H., Quintela, I. A., Wu, V. C. H., & Lin, C.-S.
(2025). Using Nano-Luciferase Binary (NanoBiT) Technology to Assess the Interaction Between Viral Spike Protein and Angiotensin-Converting Enzyme II by Aptamers. BioTech, 14(1), 20.
https://doi.org/10.3390/biotech14010020